Buda Juice, Inc. (BUDA)
AMEX AMEX Primary 
Buda Juice: The Optionality Isn't Mine
Buda Juice remains a 'sell,' as the current valuation at ~8x sales is unjustified given modest growth and execution risks. Country Fresh's distribution partnership offers scale, but minority shareholders face the risk of value leakage and lack of upside optionality. FY 2025 revenue reached $12.6M, well below full capacity, with gross margin contracting to 44.4% and FCF yield just over 2.3%.
Buda Juice: A Cold Chain Story With Hot IPO Expectations
Buda Juice is a newly public, founder-led organic juice company with a volatile, low-float stock and strong initial margins. BUDA's asset-light, Texas-centric model yields 31%+ EBITDA margins, but scaling nationwide risks margin compression and higher SG&A. Valuation appears stretched at ~26.6x EBITDA; fair value estimates ($6.70–$8.70) imply 15% downside from current levels.
